Hls Therapeutics
(TSX) HLS
Hls Therapeutics Financials at a Glance
Market Cap
$141.67M
Revenue (TTM)
$55.76M
Net Income (TTM)
$10.27M
EPS (TTM)
$-0.45
P/E Ratio
-10.02
Dividend
$0.00
Beta (Volatility)
0.49 (Low)
Dividend
$0.00
Beta (Volatility)
0.49 (Low)
Price
$4.42
Volume
200
Open
$4.42
Price
$4.42
Volume
200
Open
$4.42
Previous Close
$4.53
Daily Range
$4.42 - $4.42
52-Week Range
$4.22 - $5.76
Dividend
$0.00
Beta (Volatility)
0.49 (Low)
Price
$4.42
Volume
200
Open
$4.42
Previous Close
$4.53
Daily Range
$4.42 - $4.42
52-Week Range
$4.22 - $5.76
HLS News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Hls Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
85
CEO
Craig Millian, MBA
Website
www.hlstherapeutics.comHeadquarters
Etobicoke, ON M9W 6L2, CA
HLS Financials
Key Financial Metrics (TTM)
Gross Margin
62%
Operating Margin
-7%
Net Income Margin
-18%
Return on Equity
-16%
Return on Capital
-4%
Return on Assets
-8%
Earnings Yield
-9.98%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$141.67M
Shares Outstanding
31.27M
Volume
200
Avg. Volume
7.21K
Financials (TTM)
Gross Profit
$24.01M
Operating Income
$4.18M
EBITDA
$18.02M
Operating Cash Flow
$16.02M
Capital Expenditure
$208.59K
Free Cash Flow
$15.81M
Cash & ST Invst.
$11.70M
Total Debt
$49.73M
Hls Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$12.65M
+0.2%
Gross Profit
$4.57M
-55.3%
Gross Margin
36.12%
N/A
Market Cap
$141.67M
N/A
Market Cap/Employee
$1.54M
N/A
Employees
92
N/A
Net Income
$2.26M
+49.1%
EBITDA
$3.27M
+11.9%
Quarterly Fundamentals
Net Cash
$31.63M
+31.3%
Accounts Receivable
$8.14M
+16.6%
Inventory
$7.37M
-1.5%
Long Term Debt
$39.24M
-32.4%
Short Term Debt
$4.72M
-17.1%
Return on Assets
-7.82%
N/A
Return on Invested Capital
-3.99%
N/A
Free Cash Flow
$6.26M
+77.8%
Operating Cash Flow
$6.26M
+76.8%